Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2012 News

2012 News

All news items from 2012

Wrapped up in making a difference

by Mary Ruth last modified Jan 03, 2012 01:58 PM

Tori Frahm has experienced just eight Christmases, but she epitomizes the true spirit of the holiday. She and her family organized collection and delivery of 750 presents for pediatric oncology patients and their siblings at UNC Lineberger Comprehensive Cancer Center. The gifts helped 125 families have a brighter holiday.

Wrapped up in making a difference - Read More…

Hepatitis C virus hijacks liver microRNA

Hepatitis C virus hijacks liver microRNA

by Mary Ruth last modified Jan 03, 2012 12:36 PM

Mechanism explains how virus survives in the liver and how a new antiviral works

Hepatitis C virus hijacks liver microRNA - Read More…

Nancy Thomas, MD, PhD, appointed first Irene and Robert Alan Briggaman Distinguished Professor

Nancy Thomas, MD, PhD, appointed first Irene and Robert Alan Briggaman Distinguished Professor

by Mary Ruth last modified Jan 04, 2012 11:17 AM

Nancy E. Thomas, MD, PhD, was appointed the first Irene and Robert Alan Briggaman Distinguished Professor. The professorship is named in honor of Dr. Briggaman, who served as chair of the UNC Department of Dermatology from 1987-1999, and his wife, Irene.

Nancy Thomas, MD, PhD, appointed first Irene and Robert Alan Briggaman Distinguished Professor - Read More…

UNC GI oncologists author editorial in the Journal of Clinical Oncology

UNC GI oncologists author editorial in the Journal of Clinical Oncology

by Mary Ruth last modified Jan 05, 2012 01:20 PM

UNC Lineberger GI Oncology program directors Joel Tepper, MD, and Bert O’Neil, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Tepper is the Hector McLean Distinguished Professor of Cancer Research. O’Neil is associate professor of medicine.

UNC GI oncologists author editorial in the Journal of Clinical Oncology - Read More…

New research study examines behavioral economics of colorectal cancer screening in underserved populations

New research study examines behavioral economics of colorectal cancer screening in underserved populations

by Mary Ruth last modified Jan 05, 2012 03:31 PM

CHAPEL HILL, N.C. – A new study at UNC Chapel Hill will examine what complex and conjoined behavioral factors influence low income people to pursue colorectal cancer screening and what strategies could increase screening rates in disadvantaged communities.

New research study examines behavioral economics of colorectal cancer screening in underserved populations - Read More…

Gonzalez-Crespo talks about his work as a Spanish interpreter and what it means to him

Gonzalez-Crespo talks about his work as a Spanish interpreter and what it means to him

by Mary Ruth last modified Jan 06, 2012 11:38 AM

Ruben Gonzalez-Crespo, a Spanish interpreter at UNC Lineberger Comprehensive Cancer Center, was highlighted in the November 2011 issue of the University Gazette in an article titled "Former singer finds new voice helping others battle cancer."

Gonzalez-Crespo talks about his work as a Spanish interpreter and what it means to him - Read More…

Haithcock talks about esophageal cancer in recent interview

Haithcock talks about esophageal cancer in recent interview

by Mary Ruth last modified Jan 09, 2012 11:03 AM

Benjamin E. Haithcock, MD, an assistant professor in UNC's Division of Cardiothoracic Surgery and a member of UNC Lineberger, discussed esophageal cancer in an interview that was aired on the January 5, 2012 segment of the radio show "Make it Happen."

Haithcock talks about esophageal cancer in recent interview - Read More…

Technology tackles dieting and exercise, Tate comments

Technology tackles dieting and exercise, Tate comments

by Mary Ruth last modified Jan 09, 2012 03:06 PM

Deborah Tate, PhD, associate professor in the Department of Health Behavior and Health Education and the Department of Nutrition at UNC-Chapel Hill, is quoted in the article "Latest gadgets give diets, workouts a high-tech boost" published in today's issue of The News & Observer.

Technology tackles dieting and exercise, Tate comments - Read More…

UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer

UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer

by Mary Ruth last modified Jan 10, 2012 10:38 AM

UNC Lineberger Geriatric Oncology program leaders Hy Muss, MD, and Jan Busby-Whitehead, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Muss is professor of medicine. Busby-Whitehead is professor of medicine, and director of the UNC School of Medicine’s Center for Aging and Health and Division of Geriatric Medicine.

UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer - Read More…

UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis

UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis

by Mary Ruth last modified Jan 11, 2012 01:03 PM

Timothy Zagar, MD, assistant professor of radiation oncology, and Lawrence Marks, MD, professor and chair of radiation oncology, co-authored an editorial in the December 27, 2011 issue of the Journal of Clinical Oncology.

UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis - Read More…

Tar Heel 3-point shots benefit UNC Lineberger thanks to Coca-Cola

by Mary Ruth last modified Jan 12, 2012 02:07 PM

Coca-Cola and Tar Heel Athletics team up to help cancer research and treatment.

Tar Heel 3-point shots benefit UNC Lineberger thanks to Coca-Cola - Read More…

Chase Jones pitches Basebald for the Cure to teams across the country

by Mary Ruth last modified Jan 13, 2012 09:54 AM

When Chase Jones organized Basebald for the Cure, he hit a home run!

Chase Jones pitches Basebald for the Cure to teams across the country - Read More…

UNC surgeons co-author study on breast cancer treatment decision making

UNC surgeons co-author study on breast cancer treatment decision making

by Mary Ruth last modified Jan 18, 2012 02:41 PM

Chapel Hill, NC - How much medical information does a woman understand and retain about her breast cancer diagnosis? UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence.

UNC surgeons co-author study on breast cancer treatment decision making - Read More…

Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting

by Mary Ruth last modified Feb 14, 2012 02:54 PM

As part of Patient Power® coverage of the annual meeting of the American Society of Hematology (ASH), UNC Lineberger member Steven Park, MD, talks about the latest in treatment for Hodgkin Lymphoma.

Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting - Read More…

UNC scientists collaborate to find first major genetic mutation associated with hereditary prostate cancer risk

UNC scientists collaborate to find first major genetic mutation associated with hereditary prostate cancer risk

by Mary Ruth last modified Jan 18, 2012 11:14 AM

Chapel Hill - After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.

UNC scientists collaborate to find first major genetic mutation associated with hereditary prostate cancer risk - Read More…

UNC scientists collaborate on colon cancer therapy comparative effectiveness study

UNC scientists collaborate on colon cancer therapy comparative effectiveness study

by Mary Ruth last modified Jan 20, 2012 03:36 PM

In 2008 UNC and Harvard University’s Brigham and Women’s Hospital in Boston were selected by the U.S. Agency for Healthcare Research and Quality to carry out accelerated practical studies examining the comparative effectiveness of cancer treatments. The collaboration is called the Cancer Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Comparative Effectiveness Consortium.

UNC scientists collaborate on colon cancer therapy comparative effectiveness study - Read More…

Triangle Bladder Cancer Support Group: Here to Help

Triangle Bladder Cancer Support Group: Here to Help

by Mary Ruth last modified Jan 25, 2012 10:39 AM

Bladder cancer patients in the Triangle area are not alone. They have a monthly group where “true loving support for each other” is shared, says David Langham, a bladder cancer survivor and one of the organizers of the group.

Triangle Bladder Cancer Support Group: Here to Help - Read More…

N.C. Cancer Hospital on “Great Oncology Program” list

by Mary Ruth last modified Feb 16, 2012 02:25 PM

Becker's Hospital Review has named the N.C Cancer Hospital as one of "70 Hospitals with Great Oncology Programs."

N.C. Cancer Hospital on “Great Oncology Program” list - Read More…

Marks talks about newest radiation treatment and what it offers

Marks talks about newest radiation treatment and what it offers

by Mary Ruth last modified Jan 30, 2012 05:08 PM

Lawrence Marks, MD, chair of UNC's department of radiation oncology and a UNC Lineberger member, is quoted in the article "TomoTherapy offers safer radiation" published in today's issue of The News & Observer.

Marks talks about newest radiation treatment and what it offers - Read More…

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded

by Mary Ruth last modified Feb 01, 2012 11:05 AM

The way tobacco products are marketed and sold changed with the June 2009 passage of the Family Smoking Prevention and Tobacco Control Act. For example, this law mandates larger and stronger warning labels on packs and advertising and prohibits the sale of “light” and clove cigarettes. The FDA Act also now allows states and local communities to regulate the time, place, and manner of tobacco advertising. Thus, states could restrict tobacco promotions or restrict the location of tobacco advertising.

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded - Read More…

UNC scientists publish results from breast cancer survivors wellness workshops

by Mary Ruth last modified Mar 06, 2013 08:57 AM

Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.

UNC scientists publish results from breast cancer survivors wellness workshops - Read More…

New directory helps connect low-income women to cervical cancer services in North Carolina

by Mary Ruth last modified Feb 03, 2012 10:27 AM

A new online resource is available to help connect women and adolescents to life-saving cervical cancer-related services.

New directory helps connect low-income women to cervical cancer services in North Carolina - Read More…

Weighing the difference: switching to water, diet beverages can tip the scales

Weighing the difference: switching to water, diet beverages can tip the scales

by Mary Ruth last modified Feb 13, 2012 12:42 PM

Making a simple substitution of water or diet soft drinks for drinks with calories can help people lose four to five pounds, a new University of North Carolina at Chapel Hill study shows.

Weighing the difference: switching to water, diet beverages can tip the scales - Read More…

UNC Curriculum in Genetics and Molecular Biology rated among the very best

by Mary Ruth last modified Feb 14, 2012 10:03 AM

Training the next generation of scientists is vital to continued progress in understanding cancer and all human disease. But how do students evaluate the programs offered by colleges and universities to decide which program is the best fit for them?

UNC Curriculum in Genetics and Molecular Biology rated among the very best - Read More…

First Cancer Transitions Workshop a success

First Cancer Transitions Workshop a success

by Mary Ruth last modified Feb 17, 2012 03:17 PM

UNC Lineberger’s Carolina Well and the Comprehensive Cancer Support Program (CCSP) offered a workshop on “Cancer Transitions: Promoting Wellness & Group Process” for community outreach coordinators and their community partners as well for interested UNC nurses and staff.

First Cancer Transitions Workshop a success - Read More…

Managing the impact of drug shortages

by Mary Ruth last modified Feb 24, 2012 11:16 AM

The story "Shortages Of Life-Saving Drugs Getting Worse" aired today on WFAE 90.7, Charlotte's NPR news source.

Managing the impact of drug shortages - Read More…

Men share emotional support through written messages

by Mary Ruth last modified Mar 13, 2012 09:21 AM

The story "Men find emotional support on hospital bathroom's dry erase board" aired on February 23, 2012 on WRAL.

Men share emotional support through written messages - Read More…

Testicular cancer treatment, one patient's story

by Mary Ruth last modified Mar 13, 2012 08:48 PM

UNC Lineberger patient David Alston talks about the treatment he is undergoing for testicular cancer.

Testicular cancer treatment, one patient's story - Read More…

North Carolina-based genetic resources fuel big scientific progress

by Mary Ruth last modified Mar 01, 2012 12:10 PM

Chapel Hill, NC – A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross – a “library” of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.

North Carolina-based genetic resources fuel big scientific progress - Read More…

Muss, Keith talk about cancer care and families

Muss, Keith talk about cancer care and families

by Mary Ruth last modified Mar 09, 2012 03:38 PM

Loretta Muss, Coordinator of the N.C. Cancer Hospital Patient and Family Advisory Board, and fellow board member, Ryan Keith, talked about cancer care & families on the February 25, 26, and 27 broadcasts of YOUR HEALTH®.

Muss, Keith talk about cancer care and families - Read More…

Wallen named 2012 American Urological Association Teacher of the Year

Wallen named 2012 American Urological Association Teacher of the Year

by Mary Ruth last modified Mar 05, 2012 11:40 AM

This award, initiated by the AUA Residents Committee and approved by the AUA Board, is presented annually to recognize an outstanding urology educator or program director who has dedicated a portion of his/her career to teaching residents and advancing urology graduate medical education.

Wallen named 2012 American Urological Association Teacher of the Year - Read More…

Drug helps purge hidden HIV virus, study shows

Drug helps purge hidden HIV virus, study shows

by Mary Ruth last modified Mar 08, 2012 03:05 PM

CHAPEL HILL -- A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

Drug helps purge hidden HIV virus, study shows - Read More…

Protein complex affects cells’ ability to move, respond to external cues

Protein complex affects cells’ ability to move, respond to external cues

by Mary Ruth last modified Mar 09, 2012 09:39 AM

Chapel Hill, NC – In a paper published today in the journal, Cell, a team from the University of North Carolina at Chapel Hill has explained for the first time how a long-studied protein complex affects cell migration and how external cues affect cell’s ability to migrate.

Protein complex affects cells’ ability to move, respond to external cues - Read More…

Tobacco companies, convenience stores form 'deadly alliance' to entice kids to smoke, report says

Tobacco companies, convenience stores form 'deadly alliance' to entice kids to smoke, report says

by Mary Ruth last modified Mar 09, 2012 10:23 AM

Tobacco companies have enlisted convenience stores as their most important partners in marketing tobacco products and fighting policies that reduce tobacco use, according to a report released today by leading public health organizations, including The University of North Carolina Gillings School of Global Public Health.

Tobacco companies, convenience stores form 'deadly alliance' to entice kids to smoke, report says - Read More…

Gershon receives grant to study brain tumor, develop novel therapy

Gershon receives grant to study brain tumor, develop novel therapy

by Mary Ruth last modified Mar 12, 2012 10:05 AM

Timothy Gershon, MD, PhD, assistant professor of neurology, has received a four-year National Institutes of Health Mentored Clinical Scientist Research Career Development Award grant from the National Institute of Neurologic Disease and Stroke.

Gershon receives grant to study brain tumor, develop novel therapy - Read More…

Small DNA circles found outside the chromosomes in mammalian cells and tissues, including human cells

Small DNA circles found outside the chromosomes in mammalian cells and tissues, including human cells

by Mary Ruth last modified Mar 12, 2012 04:30 PM

CHAPEL HILL, N.C. – Researchers from the University of North Carolina at Chapel Hill have helped identify a new DNA entity in mammalian cells and provided evidence that their generation leaves behind deletions in different locations of the cells’ genetic program, or genome.

Small DNA circles found outside the chromosomes in mammalian cells and tissues, including human cells - Read More…

UNC study identifies pockets of high cervical cancer rates in North Carolina

by Mary Ruth last modified Mar 14, 2012 11:22 AM

A study of cervical cancer incidence and mortality in North Carolina has revealed areas where rates are unusually high.

UNC study identifies pockets of high cervical cancer rates in North Carolina - Read More…

UNC research center receives contract to fight kidney cancer

UNC research center receives contract to fight kidney cancer

by Mary Ruth last modified Mar 15, 2012 09:53 AM

The Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill has received a contract from SAIC-Frederick, Inc. to develop potential drug leads for treating renal cell carcinoma, the most common type of kidney cancer in adults.

UNC research center receives contract to fight kidney cancer - Read More…

UNC researchers: Benefits of varenicline (Chantix) may balance certain risks

by Mary Ruth last modified Mar 19, 2012 10:38 AM

Drs. Christine E. Kistler and Adam Goldstein discuss how clinicians can better have conversations about the balance between short-term risk of adverse cardiovascular events associated with taking Chantix compared to the long-term reduction in the risk of death that results from smoking cessation.

UNC researchers: Benefits of varenicline (Chantix) may balance certain risks - Read More…

real doctors, real people - N.E.D.

real doctors, real people - N.E.D.

by Mary Ruth last modified Mar 20, 2012 03:35 PM

N.E.D. is a rock band. The members of the band are gynecologic cancer surgeons from all over the country and two of them, Dr. John Boggess and Dr. John Soper, work here at UNC Health Care.

real doctors, real people - N.E.D. - Read More…

Hiding emotions may exacerbate depression among black men who confront racial discrimination

Hiding emotions may exacerbate depression among black men who confront racial discrimination

by Mary Ruth last modified Mar 21, 2012 09:47 AM

Enduring subtle, insidious acts of racial discrimination is enough to depress anyone, but African-American men who believe that they should respond to stress with stoicism and emotional control experience more depression symptoms, according to new findings from the University of North Carolina at Chapel Hill.

Hiding emotions may exacerbate depression among black men who confront racial discrimination - Read More…

Lung cancer highlights from 2011, Weiss provides insight

Lung cancer highlights from 2011, Weiss provides insight

by Mary Ruth last modified Mar 22, 2012 09:46 AM

Jared Weiss, MD, gave a podcast titled "2011 Highlights in Lung Cancer" that was posted on cancergrace.org on March 15, 2012. In the podcast, Dr. Weiss talks about highlights in lung cancer from 2011 and also answers questions.

Lung cancer highlights from 2011, Weiss provides insight - Read More…

Aspirin use may offer cancer prevention benefits, Baron dicusses on MedPage Today

Aspirin use may offer cancer prevention benefits, Baron dicusses on MedPage Today

by Mary Ruth last modified Mar 26, 2012 10:16 AM

John Baron, MD, was interviewed by Charles Bankhead of MedPage Today on March 21, 2012 to give his perspective on three recently published reviews in "The Lancet" and "The Lancet Oncology." The reviews suggest that "regular aspirin use leads to significant reductions in the risk of cancer, metastasis, and cancer mortality."

Aspirin use may offer cancer prevention benefits, Baron dicusses on MedPage Today - Read More…

Joseph Pagano: still going “80 mph”

Joseph Pagano: still going “80 mph”

by Mary Ruth last modified Mar 26, 2012 10:38 AM

Internationally renowned virologist; past president of national cancer and international virology associations; National Academy of Science Institute of Medicine member; North Carolina Award for Science winner; revered mentor to faculty, fellows, medical and graduate students; Berryhill Lecturer; proud grandfather; dedicated squash and tennis player; and recent honoree at his eightieth birthday.

Joseph Pagano: still going “80 mph” - Read More…

UNC Lineberger scientist receives grant for pancreatic cancer research

UNC Lineberger scientist receives grant for pancreatic cancer research

by Mary Ruth last modified Apr 17, 2012 09:24 AM

The Lustgarten Foundation, the nation’s largest foundation dedicated solely to funding pancreatic cancer research, has awarded Channing Der, PhD, a $1.165 million grant to identify promising drug combinations for potential future use in clinical trials.

UNC Lineberger scientist receives grant for pancreatic cancer research - Read More…

Ollila, Burkhart talk about teenage tanning bed use

Ollila, Burkhart talk about teenage tanning bed use

by Mary Ruth last modified Mar 29, 2012 12:10 PM

David Ollila, MD, and Craig Burkhart, MD, spoke about teenage tanning bed use at a Child Fatality Task Force committee meeting on March 26, 2012. They discussed the option of banning teenagers below the age of 18 from tanning bed use.

Ollila, Burkhart talk about teenage tanning bed use - Read More…

Predictive biomarkers for lung cancer reported in laboratory finding

Predictive biomarkers for lung cancer reported in laboratory finding

by Mary Ruth last modified Mar 30, 2012 02:54 PM

A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.

Predictive biomarkers for lung cancer reported in laboratory finding - Read More…

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit

by Mary Ruth last modified Apr 02, 2012 04:42 PM

Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.

Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit - Read More…

Evans quoted in The News & Observer, Scientific American Blog

Evans quoted in The News & Observer, Scientific American Blog

by Mary Ruth last modified Apr 03, 2012 03:39 PM

James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in recent articles in The News & Observer and the Scientific American blog.

Evans quoted in The News & Observer, Scientific American Blog - Read More…

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th

by Mary Ruth last modified May 16, 2012 09:35 AM

UNC Cancer Care’s neuro-oncology program will recognize Ependymoma Awareness Day on April 19th, as part of the program’s overall efforts to increase public awareness of this rare tumor and the need for clinical studies to improve early diagnosis, standardize treatment and improve the health status of those living with this disease.

UNC’s Neuro-oncology program recognizes Ependymoma Awareness Day on April 19th - Read More…

Sharpless, Zanation honored as Health Care Heroes

Sharpless, Zanation honored as Health Care Heroes

by Mary Ruth last modified Apr 10, 2012 01:17 PM

UNC Lineberger faculty members Ned Sharpless, MD, and Adam Zanation, MD, were honored for their achievements by Triangle Business Journal as 2012 Health Care Heroes.

Sharpless, Zanation honored as Health Care Heroes - Read More…

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting

by Mary Ruth last modified Apr 11, 2012 01:50 PM

Nancy DeMore, MD, and colleagues presented an abstract at the recent Society of Surgical Oncology 65th annual cancer symposium held in Orlando, Florida in March. Dr. DeMore is an associate professor of surgery and a member of UNC Lineberger.

Dr. Nancy DeMore and UNC colleagues present triple-negative breast cancer finding at national meeting - Read More…

Gene switches do more than flip “on” or “off”

Gene switches do more than flip “on” or “off”

by Mary Ruth last modified Nov 02, 2012 09:46 AM

Chapel Hill - Anyone who’s tried a weekend home improvement project knows that to do a job right, you’ve got to have the right tools. For cells, these “tools” are proteins encoded by genes.

Gene switches do more than flip “on” or “off” - Read More…

Ten minutes could save your life: FREE Head & Neck Cancer Screenings

by Mary Ruth last modified Apr 12, 2012 02:27 PM

UNC Health Care will offer free screenings during Oral, Head and Neck Cancer Awareness Week, on Wednesday, April 25, from 1 - 4 p.m. in the Ear, Nose, & Throat Clinic on the ground floor of the N.C. Neurosciences Hospital.

Ten minutes could save your life: FREE Head & Neck Cancer Screenings - Read More…

Kinase test may yield big gains for drug-resistant cancers

by Mary Ruth last modified Apr 23, 2012 02:59 PM

Chapel Hill, NC – In a paper published today in the journal Cell, a team from the University of North Carolina at Chapel Hill unveils the first broad-based test for activation of protein kinases “en masse”, enabling measurement of the mechanism behind drug-resistant cancer and rational prediction of successful combination therapies.

Kinase test may yield big gains for drug-resistant cancers - Read More…

UNC scientists describe protein that protects against colon cancer

by Mary Ruth last modified Apr 20, 2012 11:32 AM

Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

UNC scientists describe protein that protects against colon cancer - Read More…

Study recommends national standards for tobacco use treatment

Study recommends national standards for tobacco use treatment

by Mary Ruth last modified Apr 16, 2012 12:00 PM

National Cancer Institute-designated cancer centers should lead the way

Study recommends national standards for tobacco use treatment - Read More…

Three-dimensional RNA modeling opens scientific doors

by Mary Ruth last modified Apr 17, 2012 10:05 AM

Chapel Hill, NC – In a paper published today in the journal Nature Methods, a team from the University of North Carolina at Chapel Hill demonstrates a simple, cost-effective technique for three-dimensional RNA structure prediction that will help scientists understand the structures, and ultimately the functions, of the RNA molecules that dictate almost every aspect of human cell behavior. When cell behavior goes wrong, diseases – including cancer and metabolic disorders – can be the result.

Three-dimensional RNA modeling opens scientific doors - Read More…

Coghill receives grant to study graft versus host disease

Coghill receives grant to study graft versus host disease

by ellen.degraffenreid last modified Apr 19, 2012 08:59 AM

James Coghill, MD, has received a grant of more than $529,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study a promising target for new therapies to combat graft versus host disease, a serious complication of treatment for many blood cancers.

Coghill receives grant to study graft versus host disease - Read More…

Intensity Modulated Radiation Therapy optimal for localized prostate cancer

by ellen.degraffenreid last modified Apr 19, 2012 09:01 AM

Chapel Hill - A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association. In 2012, approximately 241,740 American men will be diagnosed with prostate cancer.

Intensity Modulated Radiation Therapy optimal for localized prostate cancer - Read More…

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned

by ellen.degraffenreid last modified Apr 20, 2012 11:35 AM

A Wayne County woman doesn’t let cancer, its treatment or its recurrence get in the way of her plans to attend her oldest granddaughter’s high school graduation or her own 45th high school reunion.

Joyce Wilson: On Trips of a Lifetime, Planned and Unplanned - Read More…

UNC scientists describe protein that protects against colon cancer

by ellen.degraffenreid last modified May 03, 2012 11:26 AM

Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.

UNC scientists describe protein that protects against colon cancer - Read More…

International panel recommends new model for breast cancer care

by ellen.degraffenreid last modified Apr 23, 2012 08:21 AM

CHAPEL HILL, N.C. - As the number of breast cancer survivors increases, now estimated at 2.8 million, more will be living with the chronic effects of cancer treatments or with advanced disease.

International panel recommends new model for breast cancer care - Read More…

Armistead receives Mentored Clinical Scientist Development Award

Armistead receives Mentored Clinical Scientist Development Award

by ellen.degraffenreid last modified Apr 24, 2012 04:36 PM

Paul Armistead, MD, PhD, has received a grant of more than $396,000 from the National Heart, Lung and Blood Institute (part of the National Institutes of Health) to study leukemia stem cell-associated minor histocompatibility antigens.

Armistead receives Mentored Clinical Scientist Development Award - Read More…

New book summarizes state of eHealth applications

New book summarizes state of eHealth applications

by ellen.degraffenreid last modified May 01, 2012 08:49 AM

UNC’s Seth Noar examines intersection of technology and health

New book summarizes state of eHealth applications - Read More…

UNC junior’s research honored at American Association for Cancer Research meeting

UNC junior’s research honored at American Association for Cancer Research meeting

by ellen.degraffenreid last modified Apr 26, 2012 08:41 AM

UNC junior Molly DeCristo attended her first international scientific meeting, but not just as a participant. The American Association for Cancer Research (AACR) honored her poster with a rosette, judging it as “highly rated,” among the top 2.5 percent of those submitted.

UNC junior’s research honored at American Association for Cancer Research meeting - Read More…

36th Annual UNC Lineberger Scientific Symposium

by Ellen de Graffenreid (edegraff) last modified May 01, 2012 04:41 PM

UNC Lineberger’s 36th annual scientific symposium drew large crowds, with over 450 participants.

36th Annual UNC Lineberger Scientific Symposium - Read More…

Joseph S. Pagano receives 2012 Battle Distinguished Cancer Research Award

Joseph S. Pagano receives 2012 Battle Distinguished Cancer Research Award

by Ellen de Graffenreid (edegraff) last modified May 02, 2012 01:47 PM

Joseph S. Pagano, MD, has been awarded the fifth annual Hyman L. Battle Distinguished Cancer Research Award in recognition of his accomplishments in cancer research. Dr. Pagano is the director emeritus of UNC Lineberger Comprehensive Cancer Center.

Joseph S. Pagano receives 2012 Battle Distinguished Cancer Research Award - Read More…

Milowsky comments on new therapies for bladder cancer

Milowsky comments on new therapies for bladder cancer

by Ellen de Graffenreid (edegraff) last modified May 02, 2012 03:38 PM

Matthew Milowsky, MD, was recently quoted in the online journal Health News Digest on new therapies for bladder cancer.

Milowsky comments on new therapies for bladder cancer - Read More…

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

by Mary Ruth last modified May 03, 2012 12:02 PM

Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach.

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery - Read More…

DeSimone elected into National Academy of Sciences

DeSimone elected into National Academy of Sciences

by Mary Ruth last modified May 03, 2012 10:09 AM

Dr. Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, has been elected into the National Academy of Sciences, one of the highest honors that a U.S. scientist or engineer can receive.

DeSimone elected into National Academy of Sciences - Read More…

Review study makes recommendations to enhance Cancer Comparative Effectiveness Research

by Mary Ruth last modified May 03, 2012 03:41 PM

Which treatment for prostate cancer is most effective? Will a specific combination of cancer drugs increase patient survival for colon cancer? As the pace of scientific discovery continues to accelerate, patients and their providers face more choices and decisions about how to address their health care needs, and information that can help inform their decisions is often hard to find.

Review study makes recommendations to enhance Cancer Comparative Effectiveness Research - Read More…

UNC scientist reports ways to improve breast cancer biomarker test

UNC scientist reports ways to improve breast cancer biomarker test

by Mary Ruth last modified May 04, 2012 10:32 AM

American and Spanish researchers report potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests.

UNC scientist reports ways to improve breast cancer biomarker test - Read More…

Der receives grant funding for pancreatic cancer research

Der receives grant funding for pancreatic cancer research

by Mary Ruth last modified May 08, 2012 09:56 AM

Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.

Der receives grant funding for pancreatic cancer research - Read More…

Postdoctoral fellow receives DOD Visionary Fellowship Award

Postdoctoral fellow receives DOD Visionary Fellowship Award

by Mary Ruth last modified May 08, 2012 01:05 PM

Idoia Garcia, PhD, a postdoctoral fellow in the lab of Timothy Gershon, MD, PhD, has been awarded a Department of Defense Visionary Postdoctoral Fellowship Award. The peer-reviewed award is intended to support exceptionally talented recent medical or other doctoral graduates in their pursuit of cutting-edge, innovative, high-risk/high-impact cancer research during their postdoctoral fellowship.

Postdoctoral fellow receives DOD Visionary Fellowship Award - Read More…

Stem cells poised to self-destruct for the good of the embryo

Stem cells poised to self-destruct for the good of the embryo

by Mary Ruth last modified May 09, 2012 09:55 AM

Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.

Stem cells poised to self-destruct for the good of the embryo - Read More…

Thriving on science: in depth with Jason Lieb

Thriving on science: in depth with Jason Lieb

by Mary Ruth last modified May 11, 2012 10:21 AM

Jason Lieb likes to mix it up. A triathlete, he enjoys running, swimming and cycling. In his lab, he works in several model systems: yeast, round worms (C. elegans), fruit flies (Drosophila melanogaster) and human cell lines.

Thriving on science: in depth with Jason Lieb - Read More…

UNC Bone Marrow and Stem Cell Transplantation Program achieves outstanding outcomes

by Mary Ruth last modified May 10, 2012 02:08 PM

Chapel Hill, NC –A medical procedure called allogeneic hematopoietic cell transplantation, commonly known as a bone marrow or stem cell transplant, is the only known curative option for many patients with life-threatening blood-borne cancers such as leukemia and lymphoma.

UNC Bone Marrow and Stem Cell Transplantation Program achieves outstanding outcomes - Read More…

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

by Mary Ruth last modified May 23, 2012 10:22 AM

Chapel Hill - Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.

Molecular subtypes and genetic alterations may determine response to lung cancer therapy - Read More…

Study shows benefit of new maintenance therapy for multiple myeloma

Study shows benefit of new maintenance therapy for multiple myeloma

by Mary Ruth last modified May 14, 2012 12:56 PM

Chapel Hill, NC – Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for many patients.

Study shows benefit of new maintenance therapy for multiple myeloma - Read More…

DNA replication protein also has a role in mitosis, cancer

DNA replication protein also has a role in mitosis, cancer

by Mary Ruth last modified May 14, 2012 02:21 PM

The finding presents a possible explanation for why so many cancers possess not just genomic instability, but also more or less than the usual 46 DNA-containing chromosomes.

DNA replication protein also has a role in mitosis, cancer - Read More…

Grant to fund use of kinase test in HER2-positive breast cancer

Grant to fund use of kinase test in HER2-positive breast cancer

by Mary Ruth last modified May 15, 2012 03:49 PM

Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.

Grant to fund use of kinase test in HER2-positive breast cancer - Read More…

Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research

Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research

by Mary Ruth last modified May 23, 2012 08:48 AM

Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, professor of medicine and genetics and Associate Director for Translational Research at UNC Lineberger Comprehensive Cancer Center has been appointed the Wellcome Distinguished Professor in Cancer Research. The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, NC. The gifts were supplemented by the state of North Carolina the Distinguished Professors Endowment Trust Fund to create the endowed professorship.

Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research - Read More…

UNC study highlights diagnosis of lung cancer subtypes

UNC study highlights diagnosis of lung cancer subtypes

by Mary Ruth last modified May 17, 2012 09:24 AM

In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.

UNC study highlights diagnosis of lung cancer subtypes - Read More…

Bae-Jump to serve on NCI's Gynecologic Cancer Steering Committee

Bae-Jump to serve on NCI's Gynecologic Cancer Steering Committee

by Mary Ruth last modified May 17, 2012 03:25 PM

Victoria Bae-Jump, MD, PhD will serve a two-year term as a junior investigator on the Gynecologic Cancer Steering Committee of the National Cancer Institute, a member institute of the National Institutes of Health.

Bae-Jump to serve on NCI's Gynecologic Cancer Steering Committee - Read More…

Quest to understand Hepatitis C link with liver cancer receives $2.35 million boost

Quest to understand Hepatitis C link with liver cancer receives $2.35 million boost

by Susan Lucas last modified May 21, 2012 12:59 PM

Chapel Hill, NC – Does hepatitis C cause liver cancer due to inflammation associated with the disease, or does the virus interact with host cells in a different way to promote the development of cancer?

Quest to understand Hepatitis C link with liver cancer receives $2.35 million boost - Read More…

Discovery Suggests New Combination Therapy Strategy for Basal-Like Breast Cancers

Discovery Suggests New Combination Therapy Strategy for Basal-Like Breast Cancers

by Susan Lucas last modified May 23, 2012 09:50 AM

Chapel Hill, NC – Multiple research projects – including a 2006 study conducted at the University of North Carolina at Chapel Hill – have used DNA microarray analysis to identify several breast cancer subtypes, including luminal A, luminal B, basal-like and HER2-enriched. Simple tests are being developed to help doctors identify these subtypes and to treat their patients in a more biologically-based way. In turn, these tests have made several studies possible that indicate that basal-like, or triple negative breast cancer, is more prevalent in African Americans than their Caucasian counterparts.

Discovery Suggests New Combination Therapy Strategy for Basal-Like Breast Cancers - Read More…

UNC Oncology Chaplain Named North Carolina Chaplain of the Year

UNC Oncology Chaplain Named North Carolina Chaplain of the Year

by Susan Lucas last modified May 24, 2012 11:47 AM

Chapel Hill - Patricia Cadle, MRE, BCC, Oncology Chaplain at UNC Health Care’s Department of Pastoral Care, was honored as the 2012 Chaplain of the Year by the North Carolina Chaplains’ Association. This award is presented annually at the Association’s spring conference in recognition of “distinguished ministry in pastoral care” to a chaplain “who serves patients, community and colleagues with grace and innovation.”

UNC Oncology Chaplain Named North Carolina Chaplain of the Year - Read More…

BCBSNC Names Dr. Lisa Carey to Board of Trustees

BCBSNC Names Dr. Lisa Carey to Board of Trustees

by Mary Ruth last modified Jun 04, 2012 10:54 AM

CHAPEL HILL, N.C. – Blue Cross and Blue Shield of North Carolina (BCBSNC) has announced Dr. Lisa Carey, Medical Director of the University of North Carolina at Chapel Hill (UNC) Breast Center and Associate Director of UNC Lineberger Comprehensive Cancer Center, as the newest member of its board of trustees.

BCBSNC Names Dr. Lisa Carey to Board of Trustees - Read More…

N.C. Children's Hospital achieves high rankings in several specialties including cancer

by Mary Ruth last modified Jun 15, 2012 12:15 PM

Congratulations to the N.C. Children’s Hospital for receiving top rankings in 10 out of 10 clinical categories in U.S. News & World Report’s 2012-13 “America’s Best Children’s Hospitals” list. The N.C. Children’s Hospital is ranked 26th in cancer.

N.C. Children's Hospital achieves high rankings in several specialties including cancer - Read More…